Abstract
Brain tumors are the most common solid tumor in children, and unfortunately, they carry the highest mortality rate of any of the pediatric cancers. The tumor itself can pose significant risk to the patient due to local effects on the central nervous system which can be life threatening if not addressed quickly. In addition, treatment can also pose significant risks to the patient as damage to the brain has a much slower recovery than any other organ in the body. This can have long-term ramifications to the patient’s overall functionality for his or her lifetime.
This chapter will touch on key risks that a pediatric brain tumor patient can have and if quickly addressed can make a significant positive lifelong impact.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ostrom QT, et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2009–2013. Neuro-Oncology. 2016;18(suppl_5):v1–v75.
Ostrom QT, et al. Alex’s lemonade stand foundation infant and childhood primary brain and central nervous system tumors diagnosed in the United States in 2007–2011. Neuro-Oncology. 2015;16(Suppl 10):x1–x36.
de Blank PM, et al. Years of life lived with disease and years of potential life lost in children who die of cancer in the United States, 2009. Cancer Med. 2015;4(4):608–19.
Smith ER, Madsen JR. Cerebral pathophysiology and critical care neurology: basic hemodynamic principles, cerebral perfusion, and intracranial pressure. Semin Pediatr Neurol. 2004;11(2):89–104.
Lin AL, Avila EK. Neurologic emergencies in the patients with cancer. J Intensive Care Med. 2017;32(2):99–115.
Forsyth PA, Posner JB. Headaches in patients with brain tumors: a study of 111 patients. Neurology. 1993;43(9):1678–83.
Stocchetti N, et al. Hyperventilation in head injury: a review. Chest. 2005;127(5):1812–27.
Damek DM. Cerebral edema, altered mental status, seizures, acute stroke, leptomeningeal metastases, and paraneoplastic syndrome. Emerg Med Clin North Am. 2009;27(2):209–29.
Pater K, Puskulluoglu M, Zygulska AL. Oncological emergencies: increased intracranial pressure in solid tumours’ metastatic brain disease. Przegl Lek. 2014;71(2):91–4.
Glantz MJ, et al. Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the quality standards subcommittee of the American Academy of Neurology. Neurology. 2000;54(10):1886–93.
Kerkhof M, Vecht CJ. Seizure characteristics and prognostic factors of gliomas. Epilepsia. 2013;54(Suppl 9):12–7.
Ruda R, et al. Seizures in low-grade gliomas: natural history, pathogenesis, and outcome after treatments. Neuro-Oncology. 2012;14(Suppl 4):iv55–64.
Vecht CJ, Kerkhof M, Duran-Pena A. Seizure prognosis in brain tumors: new insights and evidence-based management. Oncologist. 2014;19(7):751–9.
Cavaliere R, Farace E, Schiff D. Clinical implications of status epilepticus in patients with neoplasms. Arch Neurol. 2006;63(12):1746–9.
Brophy GM, et al. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care. 2012;17(1):3–23.
Rossetti AO, et al. Levetiracetam and pregabalin for antiepileptic monotherapy in patients with primary brain tumors. A phase II randomized study. Neuro-Oncology. 2014;16(4):584–8.
Pollono D, et al. Spinal cord compression: a review of 70 pediatric patients. Pediatr Hematol Oncol. 2003;20(6):457–66.
Lewis DW, et al. Incidence, presentation, and outcome of spinal cord disease in children with systemic cancer. Pediatrics. 1986;78(3):438–43.
Patchell RA, et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet. 2005;366(9486):643–8.
Sylvester RK, Fisher AJ, Lobell M. Cytarabine-induced cerebellar syndrome: case report and literature review. Drug Intell Clin Pharm. 1987;21(2):177–80.
Herzig RH, et al. Cerebellar toxicity with high-dose cytosine arabinoside. J Clin Oncol. 1987;5(6):927–32.
Kwong YL, Yeung DY, Chan JC. Intrathecal chemotherapy for hematologic malignancies: drugs and toxicities. Ann Hematol. 2009;88(3):193–201.
Prete A, Corsello SM, Salvatori R. Current best practice in the management of patients after pituitary surgery. Ther Adv Endocrinol Metab. 2017;8(3):33–48.
Fenske W, Allolio B. Clinical review: current state and future perspectives in the diagnosis of diabetes insipidus: a clinical review. J Clin Endocrinol Metab. 2012;97(10):3426–37.
Loh JA, Verbalis JG. Diabetes insipidus as a complication after pituitary surgery. Nat Clin Pract Endocrinol Metab. 2007;3(6):489–94.
Mortini P, et al. Neurosurgical treatment of craniopharyngioma in adults and children: early and long-term results in a large case series. J Neurosurg. 2011;114(5):1350–9.
Williams C, et al. Hyponatremia with intracranial malignant tumor resection in children. J Neurosurg Pediatr. 2012;9(5):524–9.
Williams CN, et al. The incidence of postoperative hyponatremia and associated neurological sequelae in children with intracranial neoplasms. J Neurosurg Pediatr. 2014;13(3):283–90.
Yee AH, Burns JD, Wijdicks EF. Cerebral salt wasting: pathophysiology, diagnosis, and treatment. Neurosurg Clin N Am. 2010;21(2):339–52.
Hardesty DA, Kilbaugh TJ, Storm PB. Cerebral salt wasting syndrome in post-operative pediatric brain tumor patients. Neurocrit Care. 2012;17(3):382–7.
Adrogue HJ, Madias NE. Hyponatremia. N Engl J Med. 2000;342(21):1581–9.
Lo AC, et al. Long-term outcomes and complications in patients with craniopharyngioma: the British Columbia Cancer Agency experience. Int J Radiat Oncol Biol Phys. 2014;88(5):1011–8.
Rogers LR, et al. Morphologic magnetic resonance imaging features of therapy-induced cerebral necrosis. J Neuro-Oncol. 2011;101(1):25–32.
Drezner N, et al. Treatment of pediatric cerebral radiation necrosis: a systematic review. J Neuro-Oncol. 2016;130(1):141–8.
Sundgren PC, Cao Y. Brain irradiation: effects on normal brain parenchyma and radiation injury. Neuroimaging Clin N Am. 2009;19(4):657–68.
Greene-Schloesser D, et al. Radiation-induced brain injury: a review. Front Oncol. 2012;2:73.
Sadraei NH, et al. Treatment of cerebral radiation necrosis with bevacizumab: the cleveland clinic experience. Am J Clin Oncol. 2015;38(3):304–10.
Delishaj D, et al. Bevacizumab for the treatment of radiation-induced cerebral necrosis: a systematic review of the literature. J Clin Med Res. 2017;9(4):273–80.
Pruitt AA. Central nervous system infections in cancer patients. Semin Neurol. 2004;24(4):435–52.
Pruitt AA. CNS infections in patients with cancer. Continuum (Minneap Minn). 2012;18(2):384–405.
Baldwin KJ, Zivkovic SA, Lieberman FS. Neurologic emergencies in patients who have cancer: diagnosis and management. Neurol Clin. 2012;30(1):101–28. viii
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer International Publishing
About this chapter
Cite this chapter
Clymer, J., Manley, P.E. (2019). Neuro-oncologic Emergencies. In: Duncan, C., Talano, JA., McArthur, J. (eds) Critical Care of the Pediatric Immunocompromised Hematology/Oncology Patient. Springer, Cham. https://doi.org/10.1007/978-3-030-01322-6_3
Download citation
DOI: https://doi.org/10.1007/978-3-030-01322-6_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-01321-9
Online ISBN: 978-3-030-01322-6
eBook Packages: MedicineMedicine (R0)